Quarterly report pursuant to Section 13 or 15(d)

Fair Value Considerations (Additional Information) (Details)

v3.22.2
Fair Value Considerations (Additional Information) (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2022
Mar. 31, 2022
Mar. 31, 2021
Jun. 30, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Convertible Debt, Fair Value Disclosures $ 186.1     $ 186.1
Weighted average grant-date fair value of options granted (in Dollars per share)   $ 1.77 $ 18.52 $ 1.84
Exercise price per (in Dollars per share) $ 11.50     11.50
Restricted Stock [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Remaining stock, closing price       4.56
Grant date fair value of stock granted $ 0     $ 0